抗感至宝口服液防治小儿反复呼吸道感染的临床研究

Clinical Study on Repeated Infantile Respiratory Tract Infection Treated by Kanggan Zhibao Oral Liquor

本研究系统介绍了抗感至宝口服液与左旋咪唑对比治疗反复呼吸道感染患儿的临床观察。结果表明，抗感至宝口服液组总有效率为９３．２％，明显高于左旋咪唑对照组（Ｐ＜０．０５）。在改善患儿症状、体征方面，前者亦明显优于后者（Ｐ＜０．０５）。两药均有提高和调节机体Ｔ淋巴细胞免疫功能，并可显著增强红细胞－Ｃ３ｂ受体的花环率，使之与健康儿比较无显著性差异（Ｐ＞０．０５），提示该药的疗效可能与此有关。

The clinical observation of repeated infantile respiratory tract infection treated by Kanggan Zhibao(KGZB) oral liquor and controlled with levomisole was studied. The results showed that the total effective rate of KGZB was 93.2%, which was significantly more effective than that of the control group(p<0.05).In relieving symptoms and signs, KGZB was also superior to the control group(P<0.05). Both the KGZB and the levomisole could euhance and modulate the immunity function of T-lymphocyte and they could increase RBC-C3b receptor rosette formation rate, so that it had no significant difference in comparing with the healthy group(P>0.05). It suggested that the therapeutic mechanism was related to this.